Surgery and heated chemotherapy for thymus cancer spread
Part of Blood & lymphatic, Cancer clinical trials.
This trial tests combining surgery with heated chemotherapy delivered directly into the chest cavity for people whose thymus cancer has spread to the lining of the lung. The goal is to see if this approach is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed thymus tumor (thymic epithelial tumor).
- Imaging shows the tumor has spread to the lining of your lungs, and a team of experts believes this treatment is right for you.
- You are between 16 and 80 years old.
- You are in good enough health for surgery (ASA class I or II).
- Your major organs (heart, lungs, liver, kidneys) are working normally.
- You have not had other cancers, and you have waited at least 4 weeks since chemotherapy, 6 weeks since radiation, and 6 weeks since immunotherapy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests giving chemotherapy directly into the chest cavity during surgery for thymoma that has spread to the lining of the lung (pleura) or has come back there. The goal is to see if this approach can help control the disease and improve outcomes.
This trial tests whether additional chemotherapy after surgery can help prevent thymic cancer from coming back. It is for people who have had their thymus tumor completely removed and are in good health.
This trial studies people with thymus (thymic) cancers that have been confirmed by tissue testing. It uses tumor “molecular” (biologic/genetic) test results to guide treatment options and see how well they work.
This trial tests a new treatment given before surgery for people with advanced thymic carcinoma. It aims to shrink the tumor and make surgery more effective.
This trial studies PT-112, a new treatment, in people with thymoma or thymic carcinoma that has grown despite at least one prior platinum chemotherapy treatment. It may help shrink tumors or slow disease progression, especially when surgery is not possible.
This trial tests whether combining the immunotherapy drug adebrelimab with chemoradiation before surgery can help shrink locally advanced thymic carcinoma and improve outcomes. It is for people who have not yet received treatment for their thymic carcinoma.
Hear when a new Thymic Epithelial Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.